Evotec SE (EVO) Receivables - Other (2019 - 2026)

Evotec SE (EVO) reported Receivables - Other of $41353.1 for Q1 2026, down 27.1% on a YoY basis from $56729.2 in Q1 2025, and up 25.55% sequentially from $32936.6 in Q4 2025.

Evotec SE (EVO) Receivables - Other (2019 - 2026) Analysis & Trends

Evotec SE (EVO) has 8 years of Receivables - Other data on file, last reported at $41353.1 in Q1 2026.

  • For the quarter ending Q1 2026, Receivables - Other fell 27.1% year-over-year to $41353.1; the trailing twelve-month figure through Mar 2026 stood at $41353.1 (down 27.1% YoY), and the FY2025 full-year result was $420219.7, up 89.06% from the prior year.
  • Receivables - Other rose to $41353.1 in Q1 2026, from $32936.6 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $4.2 million in Q4 2022 to a low of $21082.0 in Q1 2022.
  • A 5-year average of $545752.8 and a median of $42930.5 in 2024 frame the typical range for Receivables - Other.
  • Across the five-year window, Receivables - Other slumped 90.45% in 2024 and surged 70.03% in 2025, its largest moves.
  • Tracing EVO's Receivables - Other over 5 years: stood at $4.2 million in 2022, then tumbled by 43.94% to $2.3 million in 2023, then tumbled by 90.45% to $222267.8 in 2024, then slumped by 85.18% to $32936.6 in 2025, then gained by 25.55% to $41353.1 in 2026.
  • Business Quant data shows EVO's Receivables - Other at $41353.1 in Q1 2026, $32936.6 in Q4 2025, and $60691.5 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 41,353.08
Mar 31, 2026 41,353.08
Dec 31, 2025 32,936.61
Dec 31, 2025 32,936.61
Sep 30, 2025 60,691.50
Sep 30, 2025 60,691.50
Jun 30, 2025 55,303.02
Jun 30, 2025 55,303.02
Mar 31, 2025 56,729.18
Mar 31, 2025 56,729.18
Dec 31, 2024 222,267.84
Dec 31, 2024 222,267.84
Sep 30, 2024 42,930.50
Sep 30, 2024 42,930.50
Mar 31, 2024 33,364.34
Mar 31, 2024 33,364.34
Dec 31, 2023 2.33 Mn
Dec 31, 2023 2.33 Mn
Dec 31, 2022 4.15 Mn
Dec 31, 2022 4.15 Mn